DPP4 and neoplasm: High pre-operative blood levels of CD26+/CD326− cells correctly predicted tumor relapse in 44.4% of the cases (Fig. 2A); by contrast, patients with normal pre-operative blood levels of CD26+/CD326− cells developed recurrence in only 5% of cases (test accuracy, 72.5%).